{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:34:49Z","timestamp":1777566889099,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["963533"],"award-info":[{"award-number":["963533"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bioorg.2021.104737","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T22:58:04Z","timestamp":1613429884000},"page":"104737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis of 4,6-diphenylpyrimidin-2-ol derivatives as new benzodiazepine receptor ligands"],"prefix":"10.1016","volume":"109","author":[{"given":"Mona","family":"Khoramjouy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshan","family":"Khoshnevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manijeh","family":"Nematpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Shahhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyed Abbas","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Faizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104737_b0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpainsymman.2019.01.010","article-title":"The association between benzodiazepines and survival in patients with cancer: a systematic review","volume":"57","author":"O'Donnell","year":"2019","journal-title":"J. Pain. Symptom. Manage."},{"key":"10.1016\/j.bioorg.2021.104737_b0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bmc.2014.12.016","article-title":"Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a] pyrimidinone and 3-amino-1,2,4-triazole derivatives","volume":"23","author":"Faizi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0015","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.bmc.2007.01.053","article-title":"Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage","volume":"15","author":"Guerrini","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New Benzodiazepins for sedation","volume":"32","author":"Cornett","year":"2018","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.bioorg.2021.104737_b0025","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner. J."},{"key":"10.1016\/j.bioorg.2021.104737_b0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1440-1681.1999.03151.x","article-title":"The 'ABC' of GABA receptors: a brief review","volume":"26","author":"Chebib","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bioorg.2021.104737_b0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABAA receptor channels","volume":"17","author":"MacDonald","year":"1994","journal-title":"Annu. Rev. Neursci."},{"key":"10.1016\/j.bioorg.2021.104737_b0040","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2014guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain. Physician."},{"key":"10.1016\/j.bioorg.2021.104737_b0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjp.0704459","article-title":"Role of the histidine residue at position 105 in the human \u03b15 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands","volume":"135","author":"Kelly","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.104737_b0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2021.104737_b0055","series-title":"Principles of Addiction Medicine","year":"2009"},{"key":"10.1016\/j.bioorg.2021.104737_b0060","doi-asserted-by":"crossref","unstructured":"D.W. Galarneau and E.J. Conrad, in: S. Deitelzweig (Ed.), Hospital Medicine Clinics, vol 4, 2015, pp. 513\u2013526.","DOI":"10.1016\/j.ehmc.2015.06.005"},{"key":"10.1016\/j.bioorg.2021.104737_b0065","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.bmc.2005.05.015","article-title":"Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation","volume":"13","author":"Selleri","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0070","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bmc.2017.02.013","article-title":"Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands","volume":"25","author":"Guerrini","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0075","doi-asserted-by":"crossref","unstructured":"A. Almasirad, M. Ghadimi, S. Mirahmadi, P. Ahmadian Kodakan, R. Jahani, M. Nazari, E. Rezaee, H. Azizian, P. Rabizadeh, S. A. Tabatabai, M. Faizi, Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists, Mol. Divers. (2021). https:\/\/doi.org\/10.1007\/s11030-021-10182-x.","DOI":"10.1007\/s11030-021-10182-x"},{"key":"10.1016\/j.bioorg.2021.104737_b0080","first-page":"517","article-title":"Evaluation of anxiolytic, sedativehypnotic and amnesic effects of novel 2-phenoxy phenyl-1,3,4 oxadizole derivatives using experimental models, Iran","volume":"14","author":"Tabatabai","year":"2015","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.104737_b0085","first-page":"539","volume":"vol. 3","year":"1990","journal-title":"Comprehensive Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104737_b0090","series-title":"Principle of Medicinal Chemistry","first-page":"221","author":"Booth","year":"1995"},{"key":"10.1016\/j.bioorg.2021.104737_b0095","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.bmcl.2004.09.072","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles","volume":"14","author":"Almasirad","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104737_b0100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bmcl.2005.02.014","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles","volume":"15","author":"Zarghi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104737_b0105","first-page":"317","article-title":"Synthesis, anticonvulsant and muscle relaxant activities of substituted 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole","volume":"54","author":"Almasirad","year":"2007","journal-title":"Acta. Chim. Slovenica"},{"key":"10.1016\/j.bioorg.2021.104737_b0110","first-page":"89","article-title":"Synthesis and anticonvulsant activity of novel 2-amino-5-[4-chloro-2-(2-chlorophenoxy) phenyl]-1,3,4-thiadiazole derivatives, DARU","author":"Foroumadi","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2021.104737_b0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1248\/cpb.56.509","article-title":"Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy) phenyl]-1, 3, 4-oxadiazoles as anticonvulsant agents","volume":"56","author":"Zarghi","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2021.104737_b0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3797\/scipharm.0803-10","article-title":"Synthesis and pharmacological evaluation of new 2-substituted-5-{2-[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles as anticonvulsant agents","volume":"76","author":"Zarghi","year":"2008","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2021.104737_b0125","first-page":"265","article-title":"Synthesis of two novel 3-amino-5-[4-chloro-2-phenoxyphenyl]-4h-1,2,4-triazoles with anticonvulsant activity","volume":"9","author":"Mahdavi","year":"2010","journal-title":"Iranian J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.104737_b0130","first-page":"103","article-title":"Design, synthesis and anticonvulsant activity of 2-(2-phenoxy) phenyl- 1,3,4-oxadiazole derivatives","volume":"12","author":"Tabatabai","year":"2013","journal-title":"Iranian J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.104737_b0135","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2174\/092986707782360097","article-title":"An updated unified pharmacophore model of the benzodiazepine binding site on GABAA receptors: correlation with comparative models","volume":"14","author":"Clayton","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0140","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1248\/cpb.16.1105","article-title":"On the benzylation of nucleosides. I. Reaction of uridine with benzyl bromide in the presence of sodium hydride","volume":"16","author":"Imura","year":"1968","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2021.104737_b0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138527212799499859","article-title":"Biginelli reaction: a green perspective","volume":"16","author":"Panda Siva","year":"2012","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0150","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1523\/JNEUROSCI.5024-05.2006","article-title":"Alpha5GABAA receptor s mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate","volume":"26","author":"Cheng","year":"2006","journal-title":"Neurosci."},{"key":"10.1016\/j.bioorg.2021.104737_b0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.nucmedbio.2013.06.010","article-title":"Comparison [(3)H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation","volume":"40","author":"Ahmadi","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2021.104737_b0160","first-page":"79","article-title":"Optimum conditions of radioligand receptor binding assay of ligands of benzodiazepine receptors","volume":"13","author":"Ahmadi","year":"2013","journal-title":"Iranian J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.104737_b0165","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1016\/j.bmc.2008.02.058","article-title":"Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA\/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies","volume":"16","author":"Guerrini","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0170","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1021\/jm020839k","article-title":"Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABAA receptor","volume":"45","author":"Kahnberg","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-4159.1982.tb10848.x","article-title":"Development of ligands at \u03b3-aminobutyrric acid type A (GABAA) receptor subtype as new agents for pain relief","volume":"38","author":"Martini","year":"1982","journal-title":"Neurochem."},{"key":"10.1016\/j.bioorg.2021.104737_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2021.104737_b0185","first-page":"245","article-title":"In vitro receptor binding assays: general methods and considerations","volume":"52","author":"Bigott-Hennkens","year":"2008","journal-title":"J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bioorg.2021.104737_b0190","doi-asserted-by":"crossref","unstructured":"H. Motulsky, R. Neubig, The GraphPad Guide to Analysing Radioligand Binding Data, 1995\u201396 by GraphPad Software, Inc. pp. 1\u201319.","DOI":"10.1002\/0471142301.ns0705s19"},{"key":"10.1016\/j.bioorg.2021.104737_b0195","unstructured":"J.P. Bennet, Methods in Binding Studies, in: H. l. Yamamura, S. J. Enna, M. J. Kuhar, (Eds.), Neurotransmitter Receptor Binding, Raven Press, New York, 1978, pp. 57\u201390."},{"key":"10.1016\/j.bioorg.2021.104737_b0200","doi-asserted-by":"crossref","unstructured":"L. Richter, C. de Graaf, W. Sieghart, Z. Varagic, M. M\u00f6rzinger, I.J. de Esch, G.F. Ecker, M. Ernst Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands, Nat. Chem. Biol. 8 (2012) 455\u2013464.","DOI":"10.1038\/nchembio.917"},{"key":"10.1016\/j.bioorg.2021.104737_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/prot.20497","article-title":"Comparing protein\u2013ligand docking programs is difficult","volume":"60","author":"Cole","year":"2005","journal-title":"Proteins: Struct. Function, Bioinform."},{"key":"10.1016\/j.bioorg.2021.104737_b0210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejmech.2006.12.022","article-title":"New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity","volume":"42","author":"Lankau","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104737_b0215","first-page":"83","article-title":"Design, synthesis and pharmacological evaluation of novel 2-[2-(2-chlorophenoxy) phenyl]-1,3,4-oxadiazole derivatives as benzodiazepine receptor agonists","volume":"11","author":"Faizi","year":"2012","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.104737_b0220","doi-asserted-by":"crossref","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2021.104737_b0225","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1248\/yakushi.127.1263","article-title":"Sedative effects of centranthus longiflorus ssp longiflorus in rats and the influence of adrenalectomy on its effect","volume":"127","author":"Suleyman","year":"2007","journal-title":"Yakugaku Zasshi Pharm. Soc. Jpn."},{"key":"10.1016\/j.bioorg.2021.104737_b0230","doi-asserted-by":"crossref","unstructured":"V. Farzanehfar, N. Naderi, F. Kobarfard, M. Faizi Determination of dibutyl phthalate neurobehavioral toxicityinmice. Food Chem. Toxicol. 94 (2016) 221\u2013226.","DOI":"10.1016\/j.fct.2016.05.006"},{"key":"10.1016\/j.bioorg.2021.104737_b0235","first-page":"565","article-title":"Experimental methods for evaluation of psychotropic agents in rodents: I-Anti-anxiety agents","volume":"35","author":"Bhattacharya","year":"1997","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.bioorg.2021.104737_b0240","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1590\/S0102-695X2013005000044","article-title":"Anxiolytic-like effect of the extract from Bowdichia virgilioides in mice","volume":"23","author":"Vieira","year":"2013","journal-title":"Braz. J. Pharmacog."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:15:06Z","timestamp":1758615306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":48,"alternative-id":["S0045206821001140"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104737","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of 4,6-diphenylpyrimidin-2-ol derivatives as new benzodiazepine receptor ligands","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104737"}}